Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:estrogen antagonist
go back to main search page
Accession:CHEBI:50837 term browser browse the term
Definition:A compound which inhibits or antagonises the biosynthesis or actions of estrogens.
Synonyms:related_synonym: oestrogen antagonist


show annotations for term's descendants           Sort by:
 





Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19770
    role 19718
      biological role 19717
        pharmacological role 18795
          antagonist 16192
            hormone antagonist 11308
              estrogen antagonist 3565
                clomiphene + 47
                danazol 18
                fulvestrant 508
                raloxifene 847
                raloxifene hydrochloride 0
                tamoxifen + 3232
                toremifene 10
Path 2
Term Annotations click to browse term
  CHEBI ontology 19770
    role 19718
      application 19363
        pharmaceutical 19235
          drug 19235
            receptor modulator 18621
              hormone receptor modulator 18596
                hormone antagonist 11308
                  estrogen antagonist 3565
                    clomiphene + 47
                    danazol 18
                    fulvestrant 508
                    raloxifene 847
                    raloxifene hydrochloride 0
                    tamoxifen + 3232
                    toremifene 10
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.